The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Rockwell Medical Inc (NASDAQ: RMTI) closed at $2.01 down -3.37% from its previous closing price of $2.08. In other words, the price has decreased by -$3.37 from its previous closing price. On the day, 0.53 million shares were traded. RMTI stock price reached its highest trading level at $2.05 during the session, while it also had its lowest trading level at $1.97.
Ratios:
For a deeper understanding of Rockwell Medical Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.56 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.70. For the most recent quarter (mrq), Quick Ratio is recorded 2.00 and its Current Ratio is at 2.41. In the meantime, Its Debt-to-Equity ratio is 0.49 whereas as Long-Term Debt/Eq ratio is at 0.40.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on November 14, 2024, initiated with a Buy rating and assigned the stock a target price of $5.
On June 24, 2019, Piper Jaffray started tracking the stock assigning a Overweight rating and target price of $10.
On May 13, 2019, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on May 13, 2019, with a $11 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 02 ’25 when Chole Timothy sold 1,001 shares for $2.05 per share. The transaction valued at 2,052 led to the insider holds 54,170 shares of the business.
Strobeck Mark sold 2,163 shares of RMTI for $4,445 on Jan 02 ’25. The President and CEO now owns 145,038 shares after completing the transaction at $2.06 per share. On Jan 02 ’25, another insider, Strobeck Mark, who serves as the Officer of the company, bought 2,163 shares for $2.06 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RMTI now has a Market Capitalization of 67223040 and an Enterprise Value of 90329520. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.66 while its Price-to-Book (P/B) ratio in mrq is 2.23. Its current Enterprise Value per Revenue stands at 0.957 whereas that against EBITDA is -102.067.
Stock Price History:
The Beta on a monthly basis for RMTI is 1.38, which has changed by 0.4054054 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, RMTI has reached a high of $5.15, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is -21.01%, while the 200-Day Moving Average is calculated to be -16.94%.
Shares Statistics:
For the past three months, RMTI has traded an average of 717.86K shares per day and 354900 over the past ten days. A total of 32.32M shares are outstanding, with a floating share count of 28.04M. Insiders hold about 13.25% of the company’s shares, while institutions hold 29.27% stake in the company. Shares short for RMTI as of 1728950400 were 823372 with a Short Ratio of 0.86, compared to 1726185600 on 397531. Therefore, it implies a Short% of Shares Outstanding of 823372 and a Short% of Float of 2.6700001.
